Polymicrobial Keratitis: Risk Factors, Clinical Characteristics, Bacterial Profile, and Antimicrobial Resistance

OBJECTIVE To describe clinical characteristics, complications, and the most prevalent microorganisms causing polymicrobial keratitis and their antibiotic sensitivities. METHODS A cross-sectional study including a consecutive analysis of patient's records with a diagnosis of bacterial keratitis with a positive culture and antibiogram report were included. Patients were grouped into those having monomicrobial and polymicrobial infection. Features studied included demographic and clinical characteristics, risk factors, Gram stain, cultures, and antibiotic sensitivity. RESULTS We included 656 patients; in 31.5% more than one microorganism was found. Seven hundred and twenty-three gram-positive bacteria were isolated, and 336 (46.5%) had polymicrobial keratitis. One hundred sixty-one gram-negative bacteria were isolated, and 99 (61.5%) from polymicrobial keratitis. Fourteen (0.60%) patients presented ring infiltrate, and 10 (71.42%) of those patients had polymicrobial keratitis (X2 10.654, P=0.001). Multivariate analysis showed that patients with history of contact lens use (odds ratio [OR] of 1.78, P=0.042), coexistent autoimmune disease (OR 4.64, P=0.03), irregular edges of the infiltrate (OR 2.06, P=0.005), and ring infiltrate (OR 6.034, P=0.005) have a higher risk for developing polymicrobial infection. In the polymicrobial group, gram-positive and gram-negative organisms showed a high sensitivity to Netilmicin. CONCLUSIONS We found a high incidence of polymicrobial keratitis. Our results suggest that it should be suspected in patients with a history of contact lens use, coexistent autoimmune disease, infiltrates with indistinct edges, and ring infiltrates. Sensitivities to moxifloxacin are lower than those reported in previous studies, but sensitivity to Netilmicin is higher.

[1]  Z. Nagy,et al.  Clinical Review of Microbial Corneal Ulcers Resulting in Enucleation and Evisceration in a Tertiary Eye Care Center in Hungary , 2020, Journal of ophthalmology.

[2]  Ho-Joon Shin,et al.  Cytopathic Change and Inflammatory Response of Human Corneal Epithelial Cells Induced by Acanthamoeba castellanii Trophozoites and Cysts , 2019, The Korean journal of parasitology.

[3]  D. Musch,et al.  Bacterial Keratitis Preferred Practice Pattern®. , 2019, Ophthalmology.

[4]  L. Reznicek,et al.  Microbial keratitis-induced endophthalmitis: incidence, symptoms, therapy, visual prognosis and outcomes , 2018, BMC Ophthalmology.

[5]  J. Rose-Nussbaumer,et al.  Update on the Management of Infectious Keratitis. , 2017, Ophthalmology.

[6]  N. Sharma,et al.  Bilateral fungal keratitis with ring infiltrates: a rare scenario , 2017, BMJ Case Reports.

[7]  A. Imran,et al.  Prevalent Bacteria and Their Sensitivity and Resistance Pattern to Antibiotics: A Study in Dhaka Medical College Hospital , 2017 .

[8]  Savitri Sharma,et al.  Comparison Between Polymicrobial and Fungal Keratitis: Clinical Features, Risk Factors, and Outcome. , 2015, American journal of ophthalmology.

[9]  A. Navas,et al.  Trends in Microbiological and Antibiotic Sensitivity Patterns in Infectious Keratitis: 10-Year Experience in Mexico City , 2015, Cornea.

[10]  D. Carr,et al.  Tumor Necrosis Factor Alpha and Interleukin-6 Facilitate Corneal Lymphangiogenesis in Response to Herpes Simplex Virus 1 Infection , 2014, Journal of Virology.

[11]  M. Ray,et al.  Triple Infection Keratitis , 2014, Eye & contact lens.

[12]  F. Ram,et al.  Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials , 2014, British Journal of Ophthalmology.

[13]  M. Srinivasan,et al.  Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features. , 2014, American journal of ophthalmology.

[14]  M. Ray,et al.  Polymicrobial Versus Monomicrobial Keratitis: A Retrospective Comparative Study , 2013, Eye & contact lens.

[15]  J. Alió,et al.  Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases , 2013, Journal of Ophthalmic Inflammation and Infection.

[16]  M. Srinivasan,et al.  The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. , 2013, JAMA ophthalmology.

[17]  P. Hossain,et al.  Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature , 2011, British Journal of Ophthalmology.

[18]  A. Shafiee,et al.  Comparison of Besifloxacin, Gatifloxacin, and Moxifloxacin Against Strains of Pseudomonas aeruginosa With Different Quinolone Susceptibility Patterns in a Rabbit Model of Keratitis , 2011, Cornea.

[19]  Virginia Vanzzini Zago,et al.  Queratomicosis en un centro de atencin oftalmolgica en la Ciudad de Mxico , 2010 .

[20]  Jan Hudzicki,et al.  Kirby-Bauer Disk Diffusion Susceptibility Test Protocol , 2009 .

[21]  Lixin Xie,et al.  Expression and potential role of major inflammatory cytokines in experimental keratomycosis , 2009, Molecular vision.

[22]  Savitri Sharma,et al.  Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade , 2009, Indian journal of ophthalmology.

[23]  V. Flores,et al.  Susceptibilidad a netilmicina en 400 cepas bacterianas aisladas de infecciones oculares , 2009 .

[24]  F. Stapleton,et al.  Risk Factors and Causative Organisms in Microbial Keratitis , 2008, Cornea.

[25]  U. Sridhar,et al.  Polymicrobial keratitis , 2006, British Journal of Ophthalmology.

[26]  J. C. Pate,et al.  Prevalence and spectrum of bacterial co-infection during fungal keratitis , 2006, British Journal of Ophthalmology.

[27]  H. Tanihara,et al.  Role of Cytokines and Chemokines in Pseudomonal Keratitis , 2005, Cornea.

[28]  E. Romanowski,et al.  Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. , 2003, American journal of ophthalmology.

[29]  P. Garg,et al.  Corneal ulcer: diagnosis and management. , 1999, Community eye health.